Anakinra 100Mg/0.67Ml Inj Syringe

DRUG6 trials

Sponsors

University of California, San Diego, University of Manchester, Assistance Publique - Hôpitaux de Paris, Democritus University of Thrace, Azienda Sanitaria-Universitaria Integrata di Udine

Conditions

Acute Respiratory Distress SyndromeAnakinraCOVID-19COVID-19 Severe Respiratory FailureChronic Kidney DiseaseEndometriosisGoutMarkers of Inflammation

Early Phase 1

Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms

University of California, San DiegoAnakinra, Endometriosis, Markers of Inflammation

Start: 2020-06-16End: 2022-01-31Target: 20Updated: 2021-05-28

Phase 1

"IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ"

Not yet recruitingNCT07503834

Nantes University HospitalPancreatic Transplant

Start: 2026-05-01End: 2029-11-01Target: 15Updated: 2026-03-31

Phase 2

SCIL-1Ra in COVID-19 Feasibility & PK/PD

TerminatedNCT04462757

University of ManchesterCOVID-19

Start: 2020-05-28End: 2020-12-23Updated: 2021-04-30

Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation

SuspendedNCT04844814

Assistance Publique - Hôpitaux de ParisChronic Kidney Disease, Gout, Renal Transplantation

Start: 2022-06-02End: 2026-08-31Target: 204Updated: 2026-02-04

Efficacy and Safety of Anakinra in Acute Respiratory Distress Syndrome

Azienda Sanitaria-Universitaria Integrata di UdineAcute Respiratory Distress Syndrome

Start: 2023-05-19End: 2025-09-19Target: 36Updated: 2023-06-22

Unknown Phase

Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19

Democritus University of ThraceCOVID-19 Severe Respiratory Failure

Start: 2020-10-25End: 2023-12-31Target: 150Updated: 2022-03-15